EQL Pharma AB (publ)

DB:7JK Stock Report

Market Cap: €167.8m

EQL Pharma Management

Management criteria checks 3/4

EQL Pharma's CEO is Axel Schorling, appointed in Aug 2022, has a tenure of 2.25 years. total yearly compensation is SEK2.26M, comprised of 72.6% salary and 27.4% bonuses, including company stock and options. directly owns 1.07% of the company’s shares, worth €1.80M. The average tenure of the management team and the board of directors is 2.3 years and 4.8 years respectively.

Key information

Axel Schorling

Chief executive officer

SEK 2.3m

Total compensation

CEO salary percentage72.6%
CEO tenure2.3yrs
CEO ownership1.1%
Management average tenure2.3yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Axel Schorling's remuneration changed compared to EQL Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

SEK 31m

Jun 30 2024n/an/a

SEK 26m

Mar 31 2024SEK 2mSEK 2m

SEK 23m

Compensation vs Market: Axel's total compensation ($USD204.83K) is below average for companies of similar size in the German market ($USD846.96K).

Compensation vs Earnings: Insufficient data to compare Axel's compensation with company performance.

CEO

Axel Schorling (38 yo)

2.3yrs

Tenure

SEK 2,262,000

Compensation

Mr. Axel Schorling has been Independent Director at Gasporox AB (publ) since 2023. Mr. Schörling is President of EQL Pharma AB (publ) from August 15, 2022. He had been the Chief Operating Officer of EQL Ph...

Leadership Team

NamePositionTenureCompensationOwnership
Christer Fahraeus
Founder & Chairman18.8yrsSEK 250.00kno data
Axel Schorling
President & CEO2.3yrsSEK 2.26m1.07%
€ 1.8m
Anna Jonsson
Chief Financial Officer2.9yrsno data0.047%
€ 79.3k
Martin Kristofferson
Chief Operating Officer2.3yrsno data0.070%
€ 116.6k
Alexander Brising
Chief Commercial Officerno datano data0.88%
€ 1.5m
Carl Lindgren
Chief Business Development Officer1.7yrsno datano data

2.3yrs

Average Tenure

50yo

Average Age

Experienced Management: 7JK's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Christer Fahraeus
Founder & Chairman18.8yrsSEK 250.00kno data
Linda Neckmar
Independent Director4.8yrsSEK 100.00k0.0086%
€ 14.4k
Anders Mansson
Independent Director6.3yrsSEK 100.00k0.034%
€ 57.7k
Per Svangren
Independent Director3.8yrsSEK 100.00k0.034%
€ 57.7k
Per Ollermark
Independent Director3.8yrsSEK 100.00kno data

4.8yrs

Average Tenure

57yo

Average Age

Experienced Board: 7JK's board of directors are considered experienced (4.8 years average tenure).